HLA-DRB1*15:01 and multiple sclerosis: A female association?

Multiple Sclerosis Journal

Volumn 18, Issue 5, 2012, Pages 569-577

  Irizar, Haritz ^a   Muñoz Culla, Maider ^a   Zuriarrain, Olaia ^a   Goyenechea, Estibaliz ^b   Castillo Triviño, Tamara ^b   Prada, Alvaro ^b   Saenz Cuesta, Matias ^b   De Juan, Dolores ^b   Lopez De Munain, Adolfo ^a,b   Olascoaga, Javier ^a,b   Otaegui, David ^a  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

Author keywords

15:01; HLA II gene expression; HLA DRB1; multiple sclerosis; sex; VDR

Indexed keywords

DNA; HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; RNA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; HLA DRB1*15:01 ANTIGEN; HLA-DRB1*15:01 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SPAIN;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 84860488313     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511426813     Document Type: Article

References (36)

1. Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet. 2008 ; 371: 283-285
2. Baranzini SE. Revealing the genetic basis of multiple sclerosis: are we there yet?. Curr Opin Genet Dev. 2011 ; 21: 317-324
3. Tiwari JL, Terasaki PI. HLA-DR and disease associations. Prog Clin Biol Res. 1981 ; 58: 151-163
4. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991 ; 38: 1-15
5. Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature. 2006 ; 443: 574-577
6. Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, et al. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J Neuroimmunol. 2005 ; 167: 108-119
7. Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I, et al. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens. 2000 ; 55: 199-205
8. Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci. 2000 ; 178: 132-135
9. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002 ; 72: 184-187
10. Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009 ; 8: 621-626
11. Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, Mann CL, et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology. 2004 ; 62: 2323-2325
12. Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, et al. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler. 2008 ; 14: 1280-1283
13. Tajouri L, Ovcaric M, Curtain R, Johnson MP, Griffiths LR, Csurhes P, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet. 2005 ; 19: 25-38
14. Achiron A, Grotto I, Balicer R, Magalashvili D, Feldman A, Gurevich M. Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis. Neurobiol Dis. 2010 ; 38: 201-209
15. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003 ; 361: 598-604
16. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL, et al. Population stratification confounds genetic association studies among Latinos. Hum Genet. 2006 ; 118: 652-664
17. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846
18. Otaegui D, Sáenz A, Martínez-Zabaleta M, Villoslada P, Fernández-Manchola I, Alvarez de, Arcaya A, et al. Mitochondrial haplogroups in Basque multiple sclerosis patients. Mult Scler. 2004 ; 10: 532-5
19. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, et al. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 2009 ; 132: 250-259
20. Zivkovic M, Stankovic A, Dincic E, Popovic M, Popovic S, Raicevic R, et al. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR. Clin Chim Acta. 2009 ; 406: 27-30
21. Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL, et al. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet. 2010 ; 19: 2331-2340
22. Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens. 2009 ; 74: 17-21
23. Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, Hamada T, et al. Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation. J Neuroimmunol. 2002 ; 128: 77-81
24. Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, DeLuca GC, Orton SM, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A. 2009 ; 106: 7542-7547
25. Fernandez O, Antiguedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol. 2009 ; 256: 1977-1988
26. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol. 1994 ; 39: 41-48
27. Martinez-Laso J, De JD, Martinez-Quiles N, Gomez-Casado E, Cuadrado E, Arnaiz-Villena A. The contribution of the HLA-A, -B, -C and -DR, -DQ DNA typing to the study of the origins of Spaniards and Basques. Tissue Antigens. 1995 ; 45: 237-245
28. Schmidt AH, Solloch UV, Baier D, Stahr A, Wassmuth R, Ehninger G, et al. Regional differences in HLA antigen and haplotype frequency distributions in Germany and their relevance to the optimization of hematopoietic stem cell donor recruitment. Tissue Antigens. 2010 ; 76: 362-379
29. Schwendimann RN, Alekseeva N. Gender issues in multiple sclerosis. Int Rev Neurobiol. 2007 ; 79: 377-392
30. Eikelenboom MJ, Killestein J, Kragt JJ, Uitdehaag BM, Polman CH. Gender differences in multiple sclerosis: cytokines and vitamin D. J Neurol Sci. 2009 ; 286: 40-42
31. Alaez C, Lin L, Flores A, Vazquez M, Munguia A, Mignot E, et al. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. BMC Med Genet. 2008 ; 9: 79
32. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol. 2002 ; 97: 2051-2057
33. Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci. 2000 ; 177: 65-71
34. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 ; 5: e1000369
35. Agliardi C, Guerini FR, Saresella M, Caputo D, Leone MA, Zanzottera M, et al. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun. 2011 ; 25: 1460-1467
36. Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Vina M, Ramsay PP, et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol. 2008 ; 181: 5473-5480